Castle Biosciences
D

CSTL

33.140
USD
-0.03
(-0.09%)
Market Closed
Last updated: · Delayed 15 min
Volume
11,129
EPS
-1
Div Yield
-
P/E
-52
Market Cap
1,012,410,662
Overview
Related Instruments
BP
BP
D
BP plc
51.320
1.280(2.56%)
51.290-0.030(-0.06%)
CNQ
CNQ
D
Canadian Natural Resources Limited
55.070
1.170(2.17%)
COP
COP
D
ConocoPhillips
150.790
5.140(3.53%)
151.150+0.360(+0.24%)
CVX
CVX
D
Chevron Corp
233.210
6.550(2.89%)
233.340+0.130(+0.06%)
SCO
SCO
D
Proshares Trust Ii Ultrashort Bloomberg Crude Oil
15.920
-0.620(-3.75%)
15.9200.000(0.00%)
TOT
TOT
D
Lionshares U.S. Equity Total Return ETF
23.876
-0.112(-0.47%)
23.8760.000(0.00%)
XOM
XOM
D
Exxon Mobil Corp
183.190
4.990(2.80%)
183.250+0.060(+0.03%)
More

Title: Castle Biosciences

Sector: Healthcare
Industry: Diagnostics & Research
Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. The company derives revenues through the delivery of test reports for its molecular diagnostic tests.
Smarter Decisions,Together
FacebookTwitterYoutubeInstagramLinkedIn
App Store
iOS
Google Play
Android

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.